Anne Mansson Kvarnhammar PhD

Dr. Anne Mansson Kvarnhammar earned her Ph.D 2009 at Lund University, Sweden, working on the immune response in allergic rhinitis. This area was further pursued during a postdoc position at Karolinska institutet. In 2012, Dr. Kvarnhammar joined Novo Nordisk, Denmark, working with developing in silico and in vitro models to predict and reduce the clinical immunogenicity to biologics as well as novel tolerance concept. In February 2017, Dr. Kvarnhammar joined Alligator Bioscience, and as Senior Scientist she is In vitro and Scientific Lead for several projects, including ATOR-1015.